Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Journal of the American Society of Nephrology : JASN|September 2, 2004
Verotoxin (shiga toxin) sensitizes renal epithelial cells to increased heme toxicity: possible implications for the hemolytic uremic syndromeMartin Bitzan, Brandi B Bickford, Gregory H Foster
Pediatric Nephrology (Berlin, Germany)|March 21, 2008
Rituximab treatment of collapsing C1q glomerulopathy: clinical and histopathological evolutionMartin Bitzan, Jodie D Ouahed, Preetha Krishnamoorthy, et al.
International Journal of Medical Microbiology : IJMM|September 5, 2018
Complement depletion and Coombs positivity in pneumococcal hemolytic uremic syndrome (pnHUS). Case series and plea to revisit an old pathogenetic conceptMartin Bitzan, Omar AlKandari, Blair Whittemore, et al.
Pediatric Nephrology (Berlin, Germany)|April 28, 2012
TNFα pathway blockade ameliorates toxic effects of FSGS plasma on podocyte cytoskeleton and β3 integrin activationMartin Bitzan, Sima Babayeva, Anil Vasudevan, et al.
Archives of Disease in Childhood|February 25, 2019
Theophylline and aminophylline for prevention of acute kidney injury in neonates and children: a systematic reviewGirish Chandra Bhatt, Priya Gogia, Martin Bitzan, et al.
ACG Case Reports Journal|December 8, 2025
Microvillus Inclusion Disease: Successful Treatment of Severe Hyponatremia With High-Dose Fludrocortisone via a Possible Gut-Mediated MechanismAli Alsarhan, Zaineh Saffarini, Christos Tzivinikos, et al.
The Journal of Infectious Diseases|August 27, 2002
Escherichia coli O157 fails to induce a long-lasting lipopolysaccharide-specific, measurable humoral immune response in children with hemolytic-uremic syndromeKerstin Ludwig, Martin Bitzan, Christoph Bobrowski, et al.
Pediatric Nephrology (Berlin, Germany)|February 9, 2010
Cryptogenic organizing pneumonia after rituximab therapy for presumed post-kidney transplant lymphoproliferative diseaseMartin Bitzan, Jodie D Ouahed, Lucy Carpineta, et al.
Antimicrobial Agents and Chemotherapy|May 6, 2009
Safety and pharmacokinetics of chimeric anti-Shiga toxin 1 and anti-Shiga toxin 2 monoclonal antibodies in healthy volunteersMartin Bitzan, Ruth Poole, Mariam Mehran, et al.
Indian Journal of Pharmacology|March 24, 2023
Efficacy and safety of levamisole in childhood nephrotic syndrome: A meta-analysisGirish Chandra Bhatt, Bhupeshwari Patel, Rashmi Ranjan Das, et al.
Pageof 6